Search for data related to genes or regions
+
27 Study Datasets reported containing markers in gene or region 12p13.33 (no 5′ and no 3′ flanks) with -log p ≥ 3
No data sets (in No Phenotypes) added to Browser
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
Amyotrophic lateral sclerosis (HGVPM96)
  • Amyotrophic Lateral Sclerosis
512,741 GWAS of amyotrophic lateral sclerosis (HGVST65)
Amyotrophic lateral sclerosis (HGVPM648)
  • Amyotrophic Lateral Sclerosis
7,184 GWAS of sporadic amyotrophic lateral sclerosis (HGVST375)
Asthma (HGVPM1101)
  • Asthma
546,180 GWAS of asthma (HGVST631)
Bipolar disorder (HGVPM213)
  • Bipolar Disorder
21 GWAS of bipolar disorder (HGVST163)
Bipolar disorder and major depressive disorder (HGVPM791)
  • Depressive Disorder, Major
  • Bipolar Disorder
9 GWAS of bipolar disorder and major depressive disorder (HGVST450)
Body mass index (HGVPM1111)
  • Body Mass Index
38 GWAS of body mass index (HGVST640)
Body mass index (HGVPM564)
  • Body Mass Index
959,443 GWAS of adult body mass index in a British population (HGVST308)
Coronary artery disease (HGVPM113)
  • Coronary Artery Disease
1,059 GWAS of coronary artery disease (HGVST75)
Crohn's disease (HGVPM34)
  • Crohn Disease
23 GWAS of Crohn's disease (HGVST24)
Diabetic nephropathy in type I diabetes (HGVPM1531)
  • Diabetic Nephropathies
706,749 Genetics of kidneys in diabetes (GoKinD) (HGVST890)
Fasting insulin-related: fasting insulin (HGVPM822)
  • Insulin
2 GWAS of glycemic traits (HGVST463)
Fasting insulin-related: homeostatic model assessment of insulin resistance (HGVPM826)
  • Insulin Resistance
2 GWAS of glycemic traits (HGVST463)
FEV1/FVC (HGVPM918)
  • Forced Expiratory Volume
3,000 GWAS of lung function (HGVST513)
Forced expiratory volume (HGVPM916)
  • Forced Expiratory Volume
3,000 GWAS of lung function (HGVST513)
Glycated hemoglobin levels (HGVPM1081)
  • Hemoglobin A, Glycosylated
11 GWAS of glycated hemoglobin levels (HGVST618)
Height (HGVPM1104)
  • Body Height
2,469,620 GWAS of height (HGVST634)
HIV-1 viral load at set point (HGVPM314)
  • HIV-1
674 GWAS of effective control of HIV-1 (HGVST202)
Narcolepsy (HGVPM165)
  • Narcolepsy
244,737 GWAS of narcolepsy in a Japanese population (HGVST115)
Nephropathy (HGVPM994)
  • Glomerulonephritis, IGA
286,197 GWAS of nephropathy (HGVST558)
Parkinson's disease (HGVPM3)
  • Parkinson Disease
792,112 GWAS of Parkinson's disease (HGVST6)
Partial epilepsies (HGVPM929)
  • Epilepsies, Partial
528,036 GWAS of partial epilepsies (HGVST522)
Principal component axis 1, CANTAB measures (HGVPM852)
  • Behavioral Sciences
100 GWAS of cognitive performance (HGVST481)
Schizophrenia (HGVPM1533)
  • Schizophrenia
1,510,341 GWAS of schizophrenia (HGVST903)
Schizophrenia (HGVPM589)
  • Schizophrenia
3,211 GWAS of schizophrenia (HGVST320)
Spatial working memory between errors (HGVPM848)
  • Neuropsychological Tests
100 GWAS of cognitive performance (HGVST481)
Two-hour glucose challenge (HGVPM769)
  • Blood Glucose
5 GWAS of glucose levels 2 hours after an oral glucose challenge (HGVST433)
Ulcerative colitis (HGVPM1256)
  • Colitis, Ulcerative
103 GWAS of ulcerative colitis (HGVST730)